CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-29 00:00 |
정기주주총회결과
|
Korean | 26.2 KB | ||
| 2023-03-29 00:00 |
[기재정정]주주총회소집결의
|
Korean | 14.1 KB | ||
| 2023-03-29 00:00 |
의결권대리행사권유참고서류
|
Korean | 39.2 KB | ||
| 2023-03-29 00:00 |
주주총회소집공고
|
Korean | 55.2 KB | ||
| 2023-03-29 00:00 |
소송등의판결ㆍ결정(의결권행사금지가처분)
|
Korean | 7.9 KB | ||
| 2023-03-28 00:00 |
[기재정정]주요사항보고서(소송등의제기)
|
Korean | 10.6 KB | ||
| 2023-03-27 00:00 |
주요사항보고서(소송등의제기)
|
Korean | 5.7 KB | ||
| 2023-03-21 00:00 |
감사보고서제출
|
Korean | 25.9 KB | ||
| 2023-03-21 00:00 |
사업보고서 (2022.12)
|
Korean | 2.5 MB | ||
| 2023-03-14 00:00 |
주주총회소집결의
|
Korean | 13.9 KB | ||
| 2023-03-14 00:00 |
주식매수선택권부여에관한신고
|
Korean | 33.5 KB | ||
| 2023-03-14 00:00 |
의결권대리행사권유참고서류
|
Korean | 111.4 KB | ||
| 2023-03-14 00:00 |
주주총회소집공고
|
Korean | 126.5 KB | ||
| 2023-02-28 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2023-02-21 00:00 |
[기재정정]투자판단관련주요경영사항(진행성 혹은 전이성 비편평 비소세포폐암 환자의 1차 치료제로서 항 PD-1항체인 camrelizumab (S…
|
Korean | 15.5 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
